AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28586713 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 156
Study 26125951 — intervention group
Group type: EXPERIMENTAL
Intervention: Tier 2 narrative language intervention, small-group (4:1), 15-20 min, twice a week, for 9 weeks
Number of subjects: 22
Study 26125951 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 22
Study 23463854 — intervention group
Group type: EXPERIMENTAL
Intervention: Ho'ouna Pono substance use prevention curriculum
Number of subjects: 0
Study 21514214 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG spectral analysis during motor imagery tasks in patients with severe brain injury (MCS and LIS)
Number of subjects: 3
Study 21514214 — intervention group
Group type: COMPARATOR
Intervention: EEG spectral analysis in healthy controls
Number of subjects: 3
Study 18003667 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine nutritional status assessment
Number of subjects: 1627
Study 18003667 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental iodine sufficiency assessment
Number of subjects: 1627
Study 18003667 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of dietary factors
Number of subjects: 1627
Study 16649871 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance intervention
Number of subjects: 481
Study 16649871 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy weight management intervention
Number of subjects: 481
Study 16649871 — intervention group
Group type: COMPARATOR
Intervention: Expressive writing control condition
Number of subjects: 481
Study 16649871 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control condition
Number of subjects: 481
Study 16649871 — intervention group
Group type: EXPERIMENTAL
Intervention: Dissonance and healthy weight interventions
Number of subjects: 481
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemistry (IHC)
Number of subjects: 563
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence in situ hybridization (FISH)
Number of subjects: 563
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: ELISA
Number of subjects: 563
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC 3+
Number of subjects: 563
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC 2+
Number of subjects: 563
Study 14614004 — intervention group
Group type: EXPERIMENTAL
Intervention: Adenocarcinomas
Number of subjects: 563
Study 10721197 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 180
Study 10721197 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 180
Study 9124849 — intervention group
Group type: EXPERIMENTAL
Intervention: Balofloxacin (Q‐35)
Number of subjects: 0
Study 9124849 — intervention group
Group type: EXPERIMENTAL
Intervention: Grepafloxacin (OPC‐17116)
Number of subjects: 0
Study 1312770 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-arterial therapy
Number of subjects: 20
Study 1312770 — intervention group
Group type: COMPARATOR
Intervention: Intravenous therapy
Number of subjects: 20
Study 3889148 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium chloride (100 mmol/day for 2 weeks)
Number of subjects: 33
Study 3889148 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 33
Study 3889148 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium loading (100 mmol/day for 5 days) in normal subjects
Number of subjects: 33
Study 30321224 — intervention group
Group type: EXPERIMENTAL
Intervention: Dat-e Adolescence program (experimental group)
Number of subjects: 1764
Study 30321224 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1764
Study 27107475 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh frozen bone allograft (FFB)
Number of subjects: 30
Study 27107475 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine bone mineral (BBM)
Number of subjects: 30
Study 24174612 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational enhancement treatment plus brief physician advice and 8 weeks of nicotine replacement therapy (NRT)
Number of subjects: 846
Study 24174612 — intervention group
Group type: COMPARATOR
Intervention: Standard care (brief physician advice and 8 weeks of NRT)
Number of subjects: 846
Study 22561511 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpleasant-negative appraisal frame
Number of subjects: 20
Study 22561511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant-positive appraisal frame
Number of subjects: 20
Study 22561511 — intervention group
Group type: COMPARATOR
Intervention: Unpleasant-neutral appraisal frame
Number of subjects: 20
Study 22561511 — intervention group
Group type: COMPARATOR
Intervention: Pleasant-neutral appraisal frame
Number of subjects: 20
Study 20593912 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol fixed maintenance dose (640 microg/18 microg per day)
Number of subjects: 2866
Study 20593912 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol maintenance and reliever therapy (320 microg/9 microg per day plus additional inhalations as needed)
Number of subjects: 2866
Study 20593912 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol/fluticasone propionate fixed maintenance dose (100 microg/500 microg per day plus terbutaline as needed)
Number of subjects: 2866
Study 20593912 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol maintenance and reliever therapy
Number of subjects: 2866
Study 20593912 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 2866
Study 19180837 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 20 mg
Number of subjects: 8901
Study 19180837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8901
Study 16254577 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 387
Study 12153791 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone IOL
Number of subjects: 70
Study 12153791 — intervention group
Group type: COMPARATOR
Intervention: Acrylic IOL
Number of subjects: 70
Study 10098429 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant postoperative radiotherapy (conventional roentgen, electron beams, and high‐energy photon beams) with a target dose of 38‐48 Gy, administered in daily fractions of 1.9‐2.4 Gy, 5 days/week.
Number of subjects: 90
Study 10098429 — intervention group
Group type: COMPARATOR
Intervention: No radiotherapy (control group).
Number of subjects: 90
Study 7726817 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills instruction (modeling, role playing, corrective feedback, differential reinforcement) with parental involvement
Number of subjects: 5
Study 1974513 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute administration of 50 mg carvedilol
Number of subjects: 0
Study 1974513 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic administration of carvedilol
Number of subjects: 0
Study 1974513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7361266 — intervention group
Group type: EXPERIMENTAL
Intervention: External pneumatic compression (EPC) of the calves applied in the operating room and recovery room
Number of subjects: 0
Study 7361266 — intervention group
Group type: COMPARATOR
Intervention: External pneumatic compression (EPC) continued during convalescence until resumption of ambulation
Number of subjects: 0
Study 31254190 — intervention group
Group type: EXPERIMENTAL
Intervention: On-demand film
Number of subjects: 0
Study 31254190 — intervention group
Group type: EXPERIMENTAL
Intervention: Insert
Number of subjects: 0
Study 31254190 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel
Number of subjects: 0
Study 31254190 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly ring
Number of subjects: 0
Study 30478094 — intervention group
Group type: EXPERIMENTAL
Intervention: Carfilzomib and dexamethasone (Kd56)
Number of subjects: 929
Study 30478094 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone (Vd)
Number of subjects: 929
Study 30478094 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Kd56 and Vd analysis
Number of subjects: 929
Study 28759403 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1 g/d for 6 months
Number of subjects: 160
Study 28759403 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 160
Study 25050872 — intervention group
Group type: COMPARATOR
Intervention: Group intervention
Number of subjects: 33
Study 25050872 — intervention group
Group type: COMPARATOR
Intervention: Individual intervention
Number of subjects: 33
Study 23771713 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous cardiac intervention (PCI)
Number of subjects: 138
Study 23771713 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 138
Study 23771713 — intervention group
Group type: COMPARATOR
Intervention: Conservative drug therapy
Number of subjects: 138
Study 23771713 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 138
Study 21649784 — intervention group
Group type: EXPERIMENTAL
Intervention: Living serum‐free cultured epidermal autograft with wound-area debridement and a four-layer compression wrap (N=10)
Number of subjects: 15
Study 21649784 — intervention group
Group type: COMPARATOR
Intervention: Wound-area debridement and a four-layer compression wrap (Control group, N=5)
Number of subjects: 15
Study 21649784 — intervention group
Group type: EXPERIMENTAL
Intervention: Living serum‐free cultured epidermal autograft
Number of subjects: 15
Study 20297707 — intervention group
Group type: EXPERIMENTAL
Intervention: Atraumatic Restorative Treatment (ART)
Number of subjects: 40
Study 20297707 — intervention group
Group type: COMPARATOR
Intervention: Conventional Restorative Treatment (CRT)
Number of subjects: 40
Study 15654267 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (10 microg/min, 20 microg/min, 30 microg/min)
Number of subjects: 6
Study 12652148 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfractionated heparin infusion with bedside aPTT testing and computerized algorithmic adjustment
Number of subjects: 1275
Study 12652148 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving target aPTT
Number of subjects: 1275
Study 12652148 — intervention group
Group type: EXPERIMENTAL
Intervention: In-range aPTTs
Number of subjects: 1275
Study 10408490 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil citrate
Number of subjects: 0
Study 10408490 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7742156 — intervention group
Group type: EXPERIMENTAL
Intervention: New microemulsion oral formulation (NEO)
Number of subjects: 12
Study 7742156 — intervention group
Group type: COMPARATOR
Intervention: Soft gelatine capsule (SGC)
Number of subjects: 12
Study 2342981 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing consultation
Number of subjects: 56
Study 2342981 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 56
Study 2342981 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study 6770400 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg oral methadone
Number of subjects: 0
Study 30414865 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives for research participation
Number of subjects: 576
Study 28319494 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma HBP levels
Number of subjects: 296
Study 28319494 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant HBP
Number of subjects: 296
Study 28319494 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin derivatives
Number of subjects: 296
Study 26552068 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2% simvastatin
Number of subjects: 0
Study 26552068 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2% atorvastatin
Number of subjects: 0
Study 26552068 — intervention group
Group type: COMPARATOR
Intervention: SRP only (control)
Number of subjects: 0
Study 24640583 — intervention group
Group type: EXPERIMENTAL
Intervention: RLX (40 mcg/d) plus rehabilitation
Number of subjects: 36
Study 21878434 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 10 mg o.d.
Number of subjects: 1279
Study 21878434 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 30 mg b.i.d.
Number of subjects: 1279
Study 21878434 — intervention group
Group type: EXPERIMENTAL
Intervention: Darexaban 60 mg o.d.
Number of subjects: 1279
Study 21878434 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1279
Study 19689801 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-delivered lifestyle intervention focusing on symptom management, lifestyle and psychosocial support, delivered over 6 months with up to 11 sessions.
Number of subjects: 350
Study 19689801 — intervention group
Group type: COMPARATOR
Intervention: Control condition (details not specified in the abstract).
Number of subjects: 350
Study 17492272 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg intravenous citalopram
Number of subjects: 90
Study 15364775 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal antibody recognizing IL-8 (800-mg loading dose; 400-mg subsequent doses)
Number of subjects: 109
Study 15364775 — intervention group
Group type: COMPARATOR
Intervention: Placebo (active buffer solution)
Number of subjects: 109
Study 11277373 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine daily chest radiographs
Number of subjects: 30
Study 9766831 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliances for the management of chronic myalgia of the jaw muscles
Number of subjects: 0
Study 8018358 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 0
Study 2596599 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (20 mg three times daily for 5 days)
Number of subjects: 8
Study 2596599 — intervention group
Group type: COMPARATOR
Intervention: Control (no prednisone)
Number of subjects: 8
Study 4119162 — intervention group
Group type: EXPERIMENTAL
Intervention: Ragweed extract immunotherapy
Number of subjects: 19
Study 4119162 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 31692660 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved invitation letter and two self-testing kits (Arm 3)
Number of subjects: 1410
Study 31692660 — intervention group
Group type: COMPARATOR
Intervention: Improved invitation letter (Arm 2)
Number of subjects: 1410
Study 31692660 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (Arm 1)
Number of subjects: 1410
Study 31692660 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 3 vs Arm 1
Number of subjects: 1410
Study 31692660 — intervention group
Group type: COMPARATOR
Intervention: Arm 2 vs Arm 1
Number of subjects: 1410
Study 31692660 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm 3 vs Arm 2
Number of subjects: 1410
Study 26184103 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional resistance training
Number of subjects: 35
Study 26184103 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic resistance training
Number of subjects: 35
Study 26184103 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 35
Study 25258175 — intervention group
Group type: EXPERIMENTAL
Intervention: Teleconsultation (TCA)
Number of subjects: 69
Study 25258175 — intervention group
Group type: COMPARATOR
Intervention: Outpatient consultation (OCA)
Number of subjects: 69
Study 23290075 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal medicine (Shaofu Zhuyu formula concentrated-granule, SFZYFG) therapy
Number of subjects: 35
Study 23290075 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 35
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: One-level instrumented posterolateral fusion with local bone graft
Number of subjects: 122
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-level instrumented posterolateral fusion with local bone graft
Number of subjects: 122
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-level instrumented posterolateral fusion with local bone graft
Number of subjects: 122
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual Analog Scale (VAS) score
Number of subjects: 122
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese Orthopedic Association Score (JOAS)
Number of subjects: 122
Study 21224776 — intervention group
Group type: EXPERIMENTAL
Intervention: Oswestry Disability Index (ODI)
Number of subjects: 122
Study 18442638 — intervention group
Group type: EXPERIMENTAL
Intervention: Berberine
Number of subjects: 84
Study 18442638 — intervention group
Group type: COMPARATOR
Intervention: Metformin (0.5 g 3 times a day)
Number of subjects: 84
Study 15890685 — intervention group
Group type: EXPERIMENTAL
Intervention: AMD3100 plus G-CSF (A + G)
Number of subjects: 0
Study 15890685 — intervention group
Group type: COMPARATOR
Intervention: G-CSF alone (G)
Number of subjects: 0
Study 11641591 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluindione plus aspirin (100 mg)
Number of subjects: 157
Study 11641591 — intervention group
Group type: COMPARATOR
Intervention: Fluindione plus placebo (anticoagulant alone)
Number of subjects: 157
Study 9617462 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hEPO 100 IU/kg
Number of subjects: 13
Study 9617462 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hEPO 200 IU/kg
Number of subjects: 13
Study 9617462 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hEPO 400 IU/kg
Number of subjects: 13
Study 9617462 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 9617462 — intervention group
Group type: EXPERIMENTAL
Intervention: r‐hEPO (all doses)
Number of subjects: 13
Study 8075028 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitomycin-vindesine-cisplatin (MVP)
Number of subjects: 196
Study 8075028 — intervention group
Group type: COMPARATOR
Intervention: Mitomycin-ifosfamide-cisplatin (MIP)
Number of subjects: 196
Study 2609991 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once daily
Number of subjects: 20
Study 2609991 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg thrice daily
Number of subjects: 20
Study 2609991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 31889306 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrate
Number of subjects: 62
Study 31889306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study 29524398 — intervention group
Group type: EXPERIMENTAL
Intervention: FES-cycling
Number of subjects: 23
Study 29524398 — intervention group
Group type: COMPARATOR
Intervention: Placebo FES-cycling
Number of subjects: 23
Study 27625301 — intervention group
Group type: EXPERIMENTAL
Intervention: MK‐7 375 µg for 12 months
Number of subjects: 148
Study 27625301 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 148
Study 24927275 — intervention group
Group type: EXPERIMENTAL
Intervention: TE5 acupuncture (n = 12)
Number of subjects: 24
Study 24927275 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture (n = 12)
Number of subjects: 24
Study 24927275 — intervention group
Group type: COMPARATOR
Intervention: Nonacupoint acupuncture (n = 12)
Number of subjects: 24
Study 22425005 — intervention group
Group type: EXPERIMENTAL
Intervention: External laryngeal manipulation (ELM)
Number of subjects: 27
Study 22425005 — intervention group
Group type: COMPARATOR
Intervention: Standard intubation (control)
Number of subjects: 27
Study 19962839 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care provided at month 2
Number of subjects: 180
Study 19962839 — intervention group
Group type: COMPARATOR
Intervention: Standard pharmacy services (Control)
Number of subjects: 180
Study 17823597 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemplative meditation combined with breathing techniques (CMBT)
Number of subjects: 52
Study 17823597 — intervention group
Group type: COMPARATOR
Intervention: No intervention
Number of subjects: 52
Study 15751670 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 200 mg added to 500 mL NaCl and perfused for 180 min after induction of anaesthesia and 100 mg PTX added to warm cardioplegic solution
Number of subjects: 60
Study 15751670 — intervention group
Group type: COMPARATOR
Intervention: Control group (saline solution as placebo)
Number of subjects: 60
Study 11384690 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric Foley catheter test
Number of subjects: 173
Study 9731907 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone and tropisetron
Number of subjects: 300
Study 9731907 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and placebo
Number of subjects: 300
Study 7994827 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-step protocol using four extrastimuli
Number of subjects: 209
Study 7994827 — intervention group
Group type: COMPARATOR
Intervention: 18-step protocol using one, two, and three extrastimuli
Number of subjects: 209
Study 7994827 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-step protocol
Number of subjects: 209
Study 7994827 — intervention group
Group type: COMPARATOR
Intervention: 18-step protocol
Number of subjects: 209
Study 2493732 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nitroglycerin therapy (active drug patches worn for 24 hours)
Number of subjects: 14
Study 2493732 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent nitroglycerin therapy (12-hour active drug followed by 12-hour nitrate-free period)
Number of subjects: 14
Study 2493732 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30042975 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial phase CT imaging
Number of subjects: 32
Study 30042975 — intervention group
Group type: COMPARATOR
Intervention: Portal venous (PV) phase imaging
Number of subjects: 32
Study 25741640 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine administered with SoloSTAR® or ClikSTAR® pens
Number of subjects: 327
Study 23663317 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad-based play audiometer
Number of subjects: 85
Study 23663317 — intervention group
Group type: COMPARATOR
Intervention: Standard play audiometry
Number of subjects: 85
Study 21124328 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 57
Study 21124328 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 57